224 related articles for article (PubMed ID: 31409309)
21. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
23. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.
Jeon SH; Chae BC; Kim HA; Seo GY; Seo DW; Chun GT; Kim NS; Yie SW; Byeon WH; Eom SH; Ha KS; Kim YM; Kim PH
J Leukoc Biol; 2007 Feb; 81(2):557-66. PubMed ID: 17053163
[TBL] [Abstract][Full Text] [Related]
25. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.
Lv ZD; Na D; Liu FN; Du ZM; Sun Z; Li Z; Ma XY; Wang ZN; Xu HM
J Exp Clin Cancer Res; 2010 Oct; 29(1):139. PubMed ID: 21034459
[TBL] [Abstract][Full Text] [Related]
26. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
27. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
[TBL] [Abstract][Full Text] [Related]
28. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Six1,TGF-β,VEGF-C that promoting tumor lymphangiogenesis in human laryngeal carcinoma xenografts in nude mice].
Wang L; Zhu MS; Tian JH; Xue HT; Liu HL; Zhang JH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1960-1964. PubMed ID: 29798275
[No Abstract] [Full Text] [Related]
31. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.
Wang X; Chen X; Fang J; Yang C
Int J Clin Exp Pathol; 2013; 6(4):586-97. PubMed ID: 23573305
[TBL] [Abstract][Full Text] [Related]
34. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
35. Effect of progesterone on Smad signaling and TGF-β/Smad-regulated genes in lung epithelial cells.
Kunzmann S; Ottensmeier B; Speer CP; Fehrholz M
PLoS One; 2018; 13(7):e0200661. PubMed ID: 30001393
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
[TBL] [Abstract][Full Text] [Related]
38. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
39. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
40. Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit.
Liang X; Zeng J; Wang L; Shen L; Ma X; Li S; Wu Y; Ma L; Ci X; Guo Q; Jia M; Shen H; Sun Y; Liu Z; Liu S; Li W; Yu H; Chen C; Jia J
Oncotarget; 2015 Jul; 6(19):17661-74. PubMed ID: 25974964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]